EVALUATION OF THE SAFETY OF ENALAPRIL IN THE TREATMENT OF HEART-FAILURE IN THE VERY OLD

被引：20

作者：

ONEILL, CJA

BOWES, SG

SULLENS, CM

ROYSTON, JP

HUNT, WB

DENHAM, MJ

DOBBS, RJ

DOBBS, SM

机构：

[1] NORTHWICK PK HOSP, CLIN RES CTR, THERAPEUT ELDERLY RES GRP, WATFORD RD, HARROW HA1 3UJ, MIDDX, ENGLAND

[2] CLIN RES CTR, DIV MED STAT, HARROW HA1 3UJ, MIDDX, ENGLAND

[3] HATFIELD POLYTECH, ACAD GRP, HATFIELD AL10 9AB, HERTS, ENGLAND

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1988年 / 35卷 / 02期

关键词：

D O I：

10.1007/BF00609243

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：143 / 150

页数：8

共 30 条

[1]

ATKINSON L, 1977, Age and Ageing, V6, P144, DOI 10.1093/ageing/6.3.144

[2] MECHANISM OF DETERIORATION IN RENAL-FUNCTION IN PATIENTS WITH RENOVASCULAR HYPERTENSION TREATED WITH ENALAPRIL [J].

BENDER, W ;

LAFRANCE, N ;

WALKER, WG .

HYPERTENSION, 1984, 6 (02) :I193-I197

[3] ENALAPRIL MALEATE AND A LYSINE ANALOG (MK-521) IN NORMAL VOLUNTEERS - RELATIONSHIP BETWEEN PLASMA DRUG LEVELS AND THE RENIN-ANGIOTENSIN SYSTEM [J].

BIOLLAZ, J ;

SCHELLING, JL ;

COMBES, BJD ;

BRUNNER, DB ;

DESPONDS, G ;

BRUNNER, HR ;

ULM, EH ;

HICHENS, M ;

GOMEZ, HJ .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (03) :363-368

[4] EFFECT OF A NEW ANGIOTENSIN CONVERTING ENZYME-INHIBITOR MK 421 AND ITS LYSINE ANALOG ON THE COMPONENTS OF THE RENIN SYSTEM IN HEALTHY-SUBJECTS [J].

BRUNNER, DB ;

DESPONDS, G ;

BIOLLAZ, J ;

KELLER, I ;

FERBER, F ;

GAVRAS, H ;

BRUNNER, HR ;

SCHELLING, JL .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (05) :461-467

[5] 2-MINUTE, 6-MINUTE, AND 12-MINUTE WALKING TESTS IN RESPIRATORY-DISEASE [J].

BUTLAND, RJA ;

PANG, J ;

GROSS, ER ;

WOODCOCK, AA ;

GEDDES, DM .

BRITISH MEDICAL JOURNAL, 1982, 284 (6329) :1607-1608

[6]

CLELAND J, 1985, BRIT HEART J, V53, P672

[7] SEVERE HYPOTENSION AFTER 1ST DOSE OF ENALAPRIL IN HEART-FAILURE [J].

CLELAND, JGF ;

DARGIE, HJ ;

MCALPINE, H ;

BALL, SG ;

MORTON, JJ ;

ROBERTSON, JIS ;

FORD, I .

BRITISH MEDICAL JOURNAL, 1985, 291 (6505) :1309-1312

[8] AN OVERVIEW OF THE CLINICAL-PHARMACOLOGY OF ENALAPRIL [J].

DAVIES, RO ;

GOMEZ, HJ ;

IRVIN, JD ;

WALKER, JF .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 18 :S215-S229

[9] THE PHARMACOKINETICS OF ENALAPRIL IN HOSPITALIZED-PATIENTS WITH CONGESTIVE-HEART-FAILURE [J].

DICKSTEIN, K ;

TILL, AE ;

AARSLAND, T ;

TJELTA, K ;

ABRAHAMSEN, AM ;

KRISTIANSON, K ;

GOMEZ, HJ ;

GREGG, H ;

HICHENS, M .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 23 (04) :403-410

[10] PRESCRIBING DIGOXIN IN GERIATRIC UNITS - THE UNEXPLAINED VARIABILITY IN DOSAGE REQUIREMENTS [J].

DOBBS, RJ ;

ROYSTON, JP ;

ONEILL, CJA ;

DESHMUKH, AA ;

NICHOLSON, PW ;

DENHAM, MJ ;

DOBBS, SM .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 32 (06) :611-614

← 1 2 3 →